Protinal CA
Protinal CA operates in the Food Processing industry, manufacturing and distributing food products to consumers and businesses.
Business. Protinal CA (PTN.CR) is a food processing company operating within the Consumer Non-Cyclicals sector. The firm generates revenue through the sale of food products. Specific details regarding operating segments, headquarters location, and primary stock exchange listings are not available in the provided data.
Analyst recommendations
3 analysts · consensus BuyAt a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Company
- EarningsFY 2026 earnings (expected)2026-08-09 · estimated
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Protinal CA (PTN.CR) is a food processing company operating within the Consumer Non-Cyclicals sector. The firm generates revenue through the sale of food products. Specific details regarding operating segments, headquarters location, and primary stock exchange listings are not available in the provided data.
- Protinal CA's financial position is currently opaque, with all key financial metrics reported as zero.
- The company's profitability and returns cannot be assessed due to the absence of revenue and income data.
- There is no available information on Protinal CA's segments or geographic exposure, limiting the understanding of its business diversification.
- Growth trajectory and future performance are indeterminate without historical or forward-looking data.
- No immediate liquidity or dilution risks are flagged, but the lack of financial data introduces uncertainty.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- No immediate filing-based liquidity or dilution flags were detected.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Derivative transactions
- Director · Stock Option (Right to Buy) → Common StockAcquired 2 400 @ $21,38grant · 2025-12-09
- Director, President and CEO · Stock Option (Right to Buy) → Common StockAcquired 163 @ $362,50grant · 2025-12-09
- Director, President and CEO · Stock Option (Right to Buy) → Common StockAcquired 595 @ $109,50grant · 2025-12-09
- Director, President and CEO · Stock Option (Right to Buy) → Common StockAcquired 568 @ $91,50grant · 2025-12-09
- Executive VP and CFO/COO · Stock Option (Right to Buy) → Common StockAcquired 142 @ $362,50grant · 2025-12-09
- Executive VP and CFO/COO · Stock Option (Right to Buy) → Common StockAcquired 495 @ $91,50grant · 2025-12-09
- Director · Stock Option (Right to Buy) → Common StockAcquired 1 600 @ $21,38grant · 2025-12-09
- Executive VP and CFO/COO · Stock Option (Right to Buy) → Common StockAcquired 518 @ $109,50grant · 2025-12-09
- Director · Stock Option (Right to Buy) → Common StockAcquired 1 200 @ $21,38grant · 2025-12-09
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Protinal CA Market data — financials · 2026-05-29
Ownership & reference
Top holders
- Institutional Investor · as of 2026-03-310,00 %$2M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2025-12-310,00 %$0M
- Investment Managers · as of 2024-06-300,00 %$0M
- Institutional Investor · as of 2026-03-310,00 %$0M
- Brokerage Firms · as of 2026-03-310,00 %$0M
Leadership
- Carl SpanaPresident, Chief Executive Officer, Director
Insider activity
- Director, President and CEO · Common StockOther 40 @ $21,38$855 · 2025-12-30
- Executive VP and CFO/COO · Common StockOther 91 @ $21,38$2K · 2025-12-30
- Executive VP and CFO/COO · Common StockOther 26 @ $21,38$556 · 2025-12-30
- Director, President and CEO · Common StockOther 143 @ $21,38$3K · 2025-12-30
- Director, President and CEO · Common StockOther 138 @ $21,38$3K · 2025-12-30
- Executive VP and CFO/COO · Common StockOther 95 @ $21,38$2K · 2025-12-30
- Executive VP and CFO/COO · Common StockSold 565 @ $16,74$9K · 2025-12-24
- Director, President and CEO · Common StockOther 395 · 2025-12-09
- Director, President and CEO · Common StockOther 380 · 2025-12-09
- Executive VP and CFO/COO · Common StockOther 345 · 2025-12-09
- Director, President and CEO · Common StockOther 110 · 2025-12-09
- Executive VP and CFO/COO · Common StockOther 95 · 2025-12-09
- Executive VP and CFO/COO · Common StockOther 330 · 2025-12-09
- Director · Common StockOther 1 000 · 2025-12-09
- Director · Common StockOther 1 300 · 2025-12-09
- Director, President and CEO · Common StockOther 51 @ $8,00$408 · 2025-11-14
- Executive VP and CFO/COO · Common StockOther 95 @ $5,50$522 · 2025-11-14
- Executive VP and CFO/COO · Common StockOther 79 @ $8,00$632 · 2025-11-14
- Executive VP and CFO/COO · Common StockOther 33 @ $8,00$264 · 2025-11-14
- Executive VP and CFO/COO · Common StockOther 22 @ $8,00$176 · 2025-11-14
- Director, President and CEO · Common StockOther 142 @ $5,50$781 · 2025-11-14
- Director, President and CEO · Common StockOther 119 @ $8,00$952 · 2025-11-14
- Director, President and CEO · Common StockOther 33 @ $8,00$264 · 2025-11-14
Short positioning
Geographic breakdown
Intel & risk
Evidence & claims
From filings & derived data- Debt-to-equity (FY 2025-12-31): 0.56xDerived (calculated)
- Current ratio (FY 2025-12-31): 2.76xDerived (calculated)
- Cash & equivalents (YoY) (2025-12-31 vs 2023-12-31): 52.6%Derived (calculated)
- Total assets (YoY) (2025-12-31 vs 2024-12-31): 316.0%Derived (calculated)
- Total liabilities (YoY) (2025-12-31 vs 2024-12-31): -39.6%Derived (calculated)
- Shareholders' equity (YoY) (2025-12-31 vs 2024-12-31): 279.7%Derived (calculated)
- Shareholders' equity (annual): USD 11.47MSEC XBRL filing
- Cash & equivalents (annual): USD 14.48MSEC XBRL filing
- Total liabilities (annual): USD 6.46MSEC XBRL filing
- Current assets (annual): USD 17.47MSEC XBRL filing
- Total assets (annual): USD 17.93MSEC XBRL filing
- Shares outstanding (annual): 1.76MSEC XBRL filing
- Current liabilities (annual): USD 6.33MSEC XBRL filing
- Capex (YoY) (2025-06-30 vs 2024-06-30): -100.0%Derived (calculated)
- Operating cash flow (YoY) (2025-06-30 vs 2024-06-30): 32.3%Derived (calculated)
- Net income (YoY) (2025-06-30 vs 2024-06-30): 41.8%Derived (calculated)
- R&D expense (YoY) (2025-06-30 vs 2024-06-30): -33.5%Derived (calculated)
- Operating income (YoY) (2025-06-30 vs 2024-06-30): 22.4%Derived (calculated)
- EPS (diluted) (YoY) (2025-06-30 vs 2024-06-30): 68.2%Derived (calculated)
- Revenue (YoY) (2025-06-30 vs 2024-06-30): -100.0%Derived (calculated)
- Capex (annual): USD 0SEC XBRL filing
- R&D expense (annual): USD 14.9MSEC XBRL filing
- Revenue (annual): USD 0SEC XBRL filing
- Operating cash flow (annual): USD -21.31MSEC XBRL filing